227 related articles for article (PubMed ID: 19153066)
1. Efficacy of adalimumab in recalcitrant hidradenitis suppurativa.
Sotiriou E; Apalla Z; Vakirlis E; Ioannides D
Eur J Dermatol; 2009; 19(2):180-1. PubMed ID: 19153066
[No Abstract] [Full Text] [Related]
2. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
Moul DK; Korman NJ
Arch Dermatol; 2006 Sep; 142(9):1110-2. PubMed ID: 16982997
[No Abstract] [Full Text] [Related]
3. Hidradenitis suppurativa managed with adalimumab.
Yamauchi PS; Mau N
J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
Harde V; Mrowietz U
J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
[TBL] [Abstract][Full Text] [Related]
5. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.
Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950
[No Abstract] [Full Text] [Related]
6. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
[TBL] [Abstract][Full Text] [Related]
7. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
Brunasso AM; Massone C
Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
[No Abstract] [Full Text] [Related]
8. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
Arenbergerova M; Gkalpakiotis S; Arenberger P
Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
[TBL] [Abstract][Full Text] [Related]
9. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab.
Scheinfeld N
J Am Acad Dermatol; 2006 Jul; 55(1):163-4. PubMed ID: 16781316
[No Abstract] [Full Text] [Related]
10. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa.
Amano M; Grant A; Kerdel FA
Int J Dermatol; 2010 Aug; 49(8):950-5. PubMed ID: 21128923
[TBL] [Abstract][Full Text] [Related]
11. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
Koilakou S; Karapiperis D; Tzathas C
Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
[No Abstract] [Full Text] [Related]
12. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
[TBL] [Abstract][Full Text] [Related]
13. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review.
Alzaga Fernandez AG; Demirci H; Darnley-Fisch DA; Steen DW
Cornea; 2010 Oct; 29(10):1189-91. PubMed ID: 20628295
[TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
[TBL] [Abstract][Full Text] [Related]
15. Management of recalcitrant hidradenitis suppurativa with ustekinumab.
Sharon VR; Garcia MS; Bagheri S; Goodarzi H; Yang C; Ono Y; Maverakis E
Acta Derm Venereol; 2012 May; 92(3):320-1. PubMed ID: 22101775
[No Abstract] [Full Text] [Related]
16. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.
Schuch A; Fischer T; Boehner A; Biedermann T; Volz T
Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952
[No Abstract] [Full Text] [Related]
17. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
Ingram JR; Burton T
Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
[No Abstract] [Full Text] [Related]
18. [Hidradenitis suppurativa. Response to treatment with infliximab].
Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
[TBL] [Abstract][Full Text] [Related]
19. Moderate to severe hidradenitis suppurativa treated with biological therapies.
Chinniah N; Cains GD
Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Reddick CL; Singh MN; Chalmers RJ
Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
